IL-17A Damages the Blood-Retinal Barrier through Activating the Janus Kinase 1 Pathway.

Byrne, Eimear M; Llorián-Salvador, María; Tang, Miao; Margariti, Andriana; Chen, Mei; Xu, Heping

Byrne, Eimear M; Llorián-Salvador, María; Tang, Miao; Margariti, Andriana; Chen, Mei; Xu, Heping.

Afiliación

Byrne EM; The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, UK.
Llorián-Salvador M; The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, UK.
Tang M; The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, UK.
Margariti A; The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, UK.
Chen M; The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, UK.
Xu H; The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, UK.

Biomedicines ; 9(7)2021 Jul 16.

Article en En | MEDLINE | ID: mdl-34356895

Palabras clave

JAK/STAT signaling; Tofacitinib Citrate; bloodretinal barrier; inflammation; interleukin-17; macular oedema; retina; retinopathy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google